Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 13, Issue -, Pages 1955-1965
Publisher
Informa UK Limited
Online
2021-02-25
DOI
10.2147/cmar.s294035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives
- (2020) Ana Oaknin et al. CURRENT OPINION IN ONCOLOGY
- Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
- (2018) Flora Nguyen Van Long et al. Cancers
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
- (2017) Joannie Lortet-Tieulent et al. JNCI-Journal of the National Cancer Institute
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
- (2017) Joannie Lortet-Tieulent et al. JNCI-Journal of the National Cancer Institute
- Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
- (2017) Virginie Marcel et al. PLoS One
- Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature
- (2016) Maud-Emmanuelle Gilles et al. CANCER RESEARCH
- Regulation of nucleolin expression by miR-194, miR-206, and HuR
- (2016) Sudeep Bose et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs
- (2016) Jian-yu Xu et al. TUMOR BIOLOGY
- A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
- (2016) Chiara D’Avino et al. Oncotarget
- Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging
- (2016) Nithya Subramanian et al. Molecular Therapy-Nucleic Acids
- AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin
- (2016) Ye Cheng et al. PLoS One
- Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity
- (2015) Jian-Yu Xu et al. Asian Pacific Journal of Cancer Prevention
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- Human anti-nucleolin recombinant immunoagent for cancer therapy
- (2015) Dario Palmieri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
- (2015) Elisabetta Benedetti et al. Oncotarget
- Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis
- (2014) Won-Tak Choi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
- (2014) XiaoDong Guo et al. Diagnostic Pathology
- Nucleolin identified by comparative mass-spectra analysis is a potential marker for invasive progression of hepatocellular carcinoma
- (2014) BIN QIAN et al. Molecular Medicine Reports
- Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
- (2014) Marina Koutsioumpa et al. Recent Patents on Anti-Cancer Drug Discovery
- Cell surface nucleolin interacts with CXCR4 receptor via the 212 c-terminal portion
- (2014) Hongxin Niu et al. TUMOR BIOLOGY
- Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer
- (2013) Wensheng Qiu et al. APMIS
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
- (2013) J. F. Wise et al. BLOOD
- Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
- (2013) Hongyun Zhao et al. PLoS One
- Interactions of Nucleolin and Ribosomal Protein L26 (RPL26) in Translational Control of Human p53 mRNA
- (2012) Jing Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice
- (2012) Kouji Banno et al. Epigenomics
- A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface Nucleoproteins
- (2011) D. Destouches et al. CANCER RESEARCH
- Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs
- (2011) Kotb Abdelmohsen et al. NUCLEIC ACIDS RESEARCH
- Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin
- (2010) Bernard Krust et al. BIOCHIMIE
- Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
- (2008) Damien Destouches et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now